US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist
  • 135.900
  • -1.030-0.75%
Close Apr 26 16:00 ET
  • 135.900
  • 0.0000.00%
Post 17:05 ET
7.84BMarket Cap-14865P/E (TTM)

Ascendis Pharma A/S Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ascendis Pharma A/S Earnings Date

Currency: EUR

Period

Q1 FY2024 Earnings Estimates

May 2, 2024

Revenue(YoY)

79.79M

+137.55%
EPS(YoY)

-1.43

+27.76%
Analyst Rating

Strong Buy

Apr 28, 2024

Ascendis Pharma A/S Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 91.069M--
May 2, 20242024/Q1-- / 79.791M--
Feb 7, 20242023/Q4137.703M / 85.606M--
Nov 7, 20232023/Q348.034M / 47.991M--
Sep 5, 20232023/Q247.393M / 37.365M--
Apr 27, 20232023/Q133.589M / 21.525M--
Feb 16, 20232022/Q422.896M / 18.846M--
Nov 2, 20222022/Q315.290M / 8.809M--
Aug 10, 20222022/Q26.160M / 5.810M--
May 11, 20222022/Q16.828M / 4.473M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 91.069M--
May 2, 20242024/Q1-- / 79.791M--
Feb 7, 20242023/Q4137.703M / 85.606M--
Nov 7, 20232023/Q348.034M / 47.991M--
Sep 5, 20232023/Q247.393M / 37.365M--
Apr 27, 20232023/Q133.589M / 21.525M--
Feb 16, 20232022/Q422.896M / 18.846M--
Nov 2, 20222022/Q315.290M / 8.809M--
Aug 10, 20222022/Q26.160M / 5.810M--
May 11, 20222022/Q16.828M / 4.473M--

Unlock Free Earnings Estimates

Ascendis Pharma A/S Earnings Reports

  • Ascendis Pharma A/S | 20-F: Registration statement / Annual report / Transition report

    Feb 7 16:24 ET

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Feb 7 16:07 ET

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 7, 2023 16:03 ET

  • Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 7, 2023 16:01 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 28, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg